awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34264302-5ACD1185-8B6C-4588-83DF-0A0832DEFE94
Q34264302-5ACD1185-8B6C-4588-83DF-0A0832DEFE94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34264302-5ACD1185-8B6C-4588-83DF-0A0832DEFE94
Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
P2860
Q34264302-5ACD1185-8B6C-4588-83DF-0A0832DEFE94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34264302-5ACD1185-8B6C-4588-83DF-0A0832DEFE94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd11b3389c308f500d70c1daac3e9bfe3789957e
P2860
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.